2026 SOT - Summary of Three Toxicity Study of Repeated Intravenous Infusion of Exatecan Derivative-ADCs to Cynomolgus Monkey
2026.09.04
2026 SOT - Overcoming the DART Assessment Bottleneck in Transgenic Mice：Study design Strategies Informed by Historical Control Data
2026.09.04
2026 SOT - Optimizing Dosing Initiation in Rabbit Embryo-Fetal Development Toxicity Studies Avoiding the Pre-implantation Window
2026.09.04
2026 SOT - Immunogenicity and Toxicity of rAAV Gene Therapies in Non-human Primates in Preclinical Safety Evaluation
2026.09.04
2026 SOT - Consideration of Implementation for Postmarketing Carcinogenicity Studies Based on a Retrospective Analysis of Approved New Drugs by US FDA in the Past Ten Years
2026.09.04
2026 SOT - Assessment of Lipid Nanoparticles (LNPs) Caused Side Effects in Preclinical Studies in Non-human Primates
2026.09.04
2026 SOT - A Novel Method for Enhanced Bone Marrow Collection in Non-human Primates Improving Yield and Cell Viability for Downstream Analysis
2026.09.04
2024 CBF - Development and application of LC-MS MS detection method for novel mRNA drug delivery system LNP in mouse plasma and tissues
2026.07.28
2023 CBF - Validation of a highly sensitive ICP-MS method for the determination of Platinum in Human Urine and Feces application to clinical excretion studies with Pt(0506)101
2026.07.28
2023 CBF - Quantitative bioanalysis of antibody-conjugated payload in human serum using a hybrid immuno-capture LC–MSMS approach Assay development, validation, and a case study
2026.07.28
